The findings showed that the migration rate of cells was significantly reduced after knocking down BIRC5 in prostate cancer cells DU145 and PC-3 at 24 and 48h compared with that in the control group (Figures 12F–H). Here, BIRC5 is linked to prostate carcinoma.